Morepen Laboratories Ltd vs Vivanza Biosciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Morepen Laboratories Ltd is ₹ 45.73 as of 11 May 15:30 . The P/E Ratio of Morepen Laboratories Ltd changed from 14.9 on March 2021 to 22.3 on March 2025 . This represents a CAGR of 8.40% over 5 yearsThe P/E Ratio of Vivanza Biosciences Ltd changed from 687.4 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Morepen Laboratories Ltd changed from ₹ 1446 crore on March 2021 to ₹ 2621 crore on March 2025 . This represents a CAGR of 12.64% over 5 yearsThe Market Cap of Vivanza Biosciences Ltd changed from ₹ 52.24 crore on March 2021 to ₹ 7.96 crore on March 2025 . This represents a CAGR of -31.36% over 5 years The revenue of Morepen Laboratories Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 487.97 crore. This represent the decline of -100% The revenue of Vivanza Biosciences Ltd for the Mar '26 is ₹ 6.37 crore as compare to the Dec '25 revenue of ₹ 45.33 crore. This represent the decline of -85.95% The ebitda of Morepen Laboratories Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 50.12 crore. This represent the decline of -100% The ebitda of Vivanza Biosciences Ltd for the Mar '26 is ₹ -0.22 crore as compare to the Dec '25 ebitda of ₹ 0.29 crore. This represent the decline of -175% The net profit of Morepen Laboratories Ltd changed from ₹ 36.17 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Vivanza Biosciences Ltd changed from ₹ 0.27 crore to ₹ -0.45 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Morepen Laboratories Ltd changed from 10.79 % on March 2025 to 10.79 % on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Vivanza Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Morepen Laboratories Ltd

Morepen Laboratories Limited is an India-based pharmaceutical company.
Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin.
The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast.
It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L. The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India.
The main plant at Parwanoo is inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine, which is the best selling anti-allergy drug globally.

About Vivanza Biosciences Ltd

Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992.
Due to recessionary trends which lead to difficult business conditions in year 1999-2000, the parenteral industry suffered a setback and due to this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015. The Company is focused in commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines.
It is presently engaged in the business of Pharmaceutical Products. Head quartered in Gujarat, India, Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.

FAQs for the comparison of Morepen Laboratories Ltd and Vivanza Biosciences Ltd

Which company has a larger market capitalization, Morepen Laboratories Ltd or Vivanza Biosciences Ltd?

Market cap of Morepen Laboratories Ltd is 2,505 Cr while Market cap of Vivanza Biosciences Ltd is 7 Cr

What are the key factors driving the stock performance of Morepen Laboratories Ltd and Vivanza Biosciences Ltd?

The stock performance of Morepen Laboratories Ltd and Vivanza Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Morepen Laboratories Ltd and Vivanza Biosciences Ltd?

As of May 12, 2026, the Morepen Laboratories Ltd stock price is INR ₹45.73. On the other hand, Vivanza Biosciences Ltd stock price is INR ₹1.99.

How do dividend payouts of Morepen Laboratories Ltd and Vivanza Biosciences Ltd compare?

To compare the dividend payouts of Morepen Laboratories Ltd and Vivanza Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.